IntegraGen SA (ALINT) Stock Statistics & Valuation Metrics

IntegraGen SA has a market cap or net worth of €1.40M. The enterprise value is €544.39K.

IntegraGen SA has 6,727,332 shares outstanding. The number of shares has decreased by -2.65% in one year.

IntegraGen SA’s return on equity (ROE) is 2.93 and return on invested capital (ROIC) is -357.59%.

The current PE Ratio of IntegraGen SA is ―. IntegraGen SA’s PEG ratio is -0.00035.

In the last 12 months, IntegraGen SA had revenue of 5.02M and earned -2.66M in profits. Earnings per share was -0.40.

In the last 12 months, operating cash flow was -1.58M and capital expenditures -2.27K, giving a free cash flow of -1.58M billion.

IntegraGen SA pays an annual dividend of ―, resulting in a dividend yield of ―

IntegraGen SA upcoming earnings date is Apr 29, 2026, TBA (Confirmed).

IntegraGen SA as a current ratio of 1.30, with Debt / Equity ratio of -33.55%

In the past 12 months, IntegraGen SA has paid -91.79K in taxes.

IntegraGen SA EV to EBITDA ratio is -0.03, with an EV/FCF ratio of -0.05.

IntegraGen SA has €1.11M in cash and marketable securities with €305.00K in debt, giving a net cash position of €810.00K billion.

Gross margin is -47.22%, with operating margin of -56.21%, and net profit margin of -53.06%.

The average price target for IntegraGen SA is ―, which is 11.43% higher than the current price. The consensus rating is ―